GSK Investigational Site
Gulfport, Mississippi 39507
0 studies enrolling now · 15 studies all time
What they study most
Anaemia, Aspergillosis, Allergic Bronchopulmonary, Asthma, Bipolar Disorder, Chickenpox, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Fibrillation, Atrial, Hypertension, Respiratory Syncytial Virus Infections
Studies at this site
- A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
- A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age — Completed
- Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants — Completed
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
- TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) — Stopped early
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
- Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
- Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
- Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
- Pharmacokinetics/Pharmacodynamics of Albiglutide — Completed
- Bipolar Study in Adults at Least 18 Years of Age — Completed
- Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension — Completed